Cryo Cell International (CCEL) Debt to Equity (2016 - 2025)
Cryo Cell International (CCEL) has disclosed Debt to Equity for 16 consecutive years, with -$0.17 as the latest value for Q4 2025.
- On a quarterly basis, Debt to Equity rose 80.94% to -$0.17 in Q4 2025 year-over-year; TTM through Nov 2025 was -$0.17, a 80.94% increase, with the full-year FY2025 number at -$0.17, up 80.94% from a year prior.
- Debt to Equity was -$0.17 for Q4 2025 at Cryo Cell International, up from -$0.77 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.22 in Q2 2021 to a low of -$222.59 in Q3 2023.
- A 5-year average of -$13.28 and a median of -$0.77 in 2025 define the central range for Debt to Equity.
- Peak YoY movement for Debt to Equity: soared 184.11% in 2021, then tumbled 7393.36% in 2023.
- Cryo Cell International's Debt to Equity stood at $0.18 in 2021, then tumbled by 1232.52% to -$2.07 in 2022, then skyrocketed by 90.79% to -$0.19 in 2023, then crashed by 370.72% to -$0.9 in 2024, then soared by 80.94% to -$0.17 in 2025.
- Per Business Quant, the three most recent readings for CCEL's Debt to Equity are -$0.17 (Q4 2025), -$0.77 (Q3 2025), and -$0.48 (Q2 2025).